TeleQuest execs leave company in restructuring

Article

TeleQuest execs leave company in restructuringTeleradiology services provider TeleQuest is reportedly restructuring its organization, due to slower than expected growth in new overread contracts at the Philadelphia company. TeleQuest CEO William

TeleQuest execs leave company in restructuring

Teleradiology services provider TeleQuest is reportedly restructuring its organization, due to slower than expected growth in new overread contracts at the Philadelphia company. TeleQuest CEO William Straub, president Michael Moore, and other high-ranking executives have left the company in recent weeks, and the company's venture-capital backers are said to be examining the firm's operations to find ways of increasing profitability.

TeleQuest was formed in 1994 with the goal of establishing a nationwide network of luminary sites that would provide subspecialty interpretation services to hospitals, imaging centers, and other healthcare providers via teleradiology links. The formation of the company was seen by many industry analysts as an example of how teleradiology would change the face of healthcare by bringing high-quality radiology interpretations to healthcare facilities.

TeleQuest has been controversial among some radiologists, however, who see the company's business model as an intrusion on their turf, and who are loath to give up lucrative subspecialty interpretations to an outside provider. TeleQuest's marketing effort may also have misfired, and the company has been unable to achieve the sales goals initially set up for it. In addition, a host of other teleradiology service providers sprang up not long after TeleQuest was formed, creating heavy competition for potential customers.

Representatives from TeleQuest's main financial backer, Fidelity Investments of Boston, are reportedly behind the company's restructuring effort. Fidelity declined to return phone calls as of press time.

One of the changes under way at TeleQuest regards the management of the company's teleradiology network, which is being turned over to Access Radiology of Natick, MA. Access in the past has provided TeleQuest with teleradiology equipment, but will take over management of the firm's network and associated support functions, tasks previously performed by TeleQuest and third-party providers.

Access maintains a 24-hour teleradiology technical support center that can be used to monitor TeleQuest's network and make sure it is running smoothly, according to Scott Sheldon, president and CEO of Access. Access can also conduct other maintenance functions, like calibrating x-ray film digitizers and ensuring that TeleQuest equipment meets American College of Radiology quality assurance specifications.

More importantly, however, the change will allow TeleQuest to focus on its core business of providing overread services while helping the company cut costs, according to Sheldon.

"We offer TeleQuest the opportunity to provide services at a lower cost than having to internally provide those support services," he said. "They want to get more squarely into the business of practicing healthcare."

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.